clinical trial · NCT06803654
A Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness
Ocular RednessBTOS-HALumify®
brief summary
To demonstrate the efficacy of BTOS-HA as non inferior to Lumify for treating ocular redness in a population of adult subjects.
started
May 22, 2025
primary completion
Jun 29, 2025
completion
Jun 29, 2025
last updated
Jul 9, 2025
official title
A Randomized, Multicenter, Double-Masked, Active-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol